Funding for Covid-19 drug development announced to two BioRN members


© BMBF/Hans-Joachim Rickel

The Federal Ministry of Health (BMG) and the Federal Ministry of Education and Research (BMBF) are continuing to drive forward the joint development of drugs and medicines against COVID 19. This week, Federal Research Minister Anja Karliczek and Federal Health Minister Jens Spahn presented six concrete research projects in which drugs that have already been tested will be clinically developed further. The selection goes back to a joint funding guideline from May.


We are glad to see among the selected research projects, two of them coordinated by BioRN members:

  • Apogenix AG

  • CORAT Therapeutics GmbH (a spin-off of YUMAB)

Original Press Release (in German)